Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Harm-reduction advocates have insisted that there are too few safer supply patients (roughly 4,500 in B.C.) to meaningfully ...

Using the BiovitalsHF software to personalize recommendations got more patients on all four pillars of therapy.

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Flatiron Health today announced its planned presence at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), including ...

Eran Ovadya, Chief Financial Officer of NurExone stated, “The ISCT 2025 conference is a key opportunity to showcase our advances and to expand our U.S. presence. As we grow Exo-Top and pursue U.S.

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

In a notable Genomic Press research report, researchers at the Aristotle University of Thessaloniki have uncovered a significant presence of manic symptoms in patients with schizophrenia spectrum ...

As interest in alternative treatment options grow, a speaker at South Beach Symposium shared her go-to nutrition guidelines for patients suffering from hair loss. “I don't know about you, but I have a ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

Q4 2024 Earnings Call Transcript February 13, 2025 CareTrust REIT, Inc. misses on earnings expectations. Reported EPS is ...

"TGFB2 has emerged as a master regulator of immune suppression, not just in cancer but across multiple chronic diseases,” said Dr. Trieu. "Our work on OT-101 aims to neutralize TGFB2-driven resistance ...